Want to join the conversation?
Sales in $AKAM's International markets represented 27% of total revenue in 3Q15, up 1 point from the prior quarter. International revenue was $150MM in the quarter, up 12% year-over-year or up 27% on a constant currency basis. Revenue from US market was $401MM, up 10% year-over-year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?